(Q43713973)

26 November 2017

title

Evaluation of two modified ECF regimens in the treatment of advanced gallbladder cancer (English)

1 reference

26 November 2017

Jian Dong Wang

1

1 reference

26 November 2017

Wei Bin Shi

2

1 reference

26 November 2017

Jun Shen

3

1 reference

26 November 2017

Peng Yuan Zhuang

4

1 reference

26 November 2017

Zhi Wei Quan

5

1 reference

26 November 2017

Xue Feng Wang

6

1 reference

26 November 2017

Xue Ping Zhou

7

1 reference

26 November 2017

Song Gang Li

8

1 reference

26 November 2017

Ying Bin Liu

9

1 reference

26 November 2017

Yong Yang

10

1 reference

26 November 2017

publication date

7 December 2010

1 reference

26 November 2017

1 reference

26 November 2017

volume

28 Suppl 1

1 reference

26 November 2017

page(s)

S295-300

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-010-9758-y

26 November 2017

exact match

0 references

cites work

Epidemiology and molecular pathology of gallbladder cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Nonsurgical management of gallbladder cancer: cytotoxic treatment and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Infusion chemotherapy with cisplatinum and fluorouracil in the treatment of locally-advanced and metastatic gallbladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9758-Y

Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancer

21 January 2018

1 reference

12 December 2020

Chemotherapy for gallbladder carcinoma--a surgeon's perspective

1 reference

12 December 2020

Comparison of time trends in gallbladder cancer incidence (1973-1997) in East Asia, Europe and the USA, from Cancer Incidence in Five Continents Vols IV-VIII

1 reference

12 December 2020

1 reference

12 December 2020

Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study

1 reference

12 December 2020

Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours

1 reference

12 December 2020

10.1007/S12032-010-9758-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

1021638850

0 references

1 reference